Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SCPS

Scopus BioPharma (SCPS)

Scopus BioPharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SCPS
DateTimeSourceHeadlineSymbolCompany
11/02/20238:15AMGlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of CancerNASDAQ:SCPSScopus BioPharma Inc
06/28/20234:16PMEdgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:SCPSScopus BioPharma Inc
05/12/20234:16PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCPSScopus BioPharma Inc
04/28/20234:05PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:SCPSScopus BioPharma Inc
04/14/20234:01PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:SCPSScopus BioPharma Inc
12/16/20225:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
12/02/20224:17PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SCPSScopus BioPharma Inc
11/21/20224:17PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCPSScopus BioPharma Inc
11/15/20224:16PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:SCPSScopus BioPharma Inc
11/10/20228:15AMGlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of CancerNASDAQ:SCPSScopus BioPharma Inc
10/18/20228:25AMGlobeNewswire Inc.Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder ValueNASDAQ:SCPSScopus BioPharma Inc
09/02/20224:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
05/27/20224:46PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
05/19/20224:16PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCPSScopus BioPharma Inc
05/13/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
05/05/20227:30AMGlobeNewswire Inc.Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of DirectorsNASDAQ:SCPSScopus BioPharma Inc
05/04/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
05/02/20223:47PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:SCPSScopus BioPharma Inc
04/29/20224:38PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
04/15/20223:18PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:SCPSScopus BioPharma Inc
04/08/20224:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
04/01/20224:17PMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:SCPSScopus BioPharma Inc
03/24/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
03/23/20225:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
03/22/20227:30PMGlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies SummitNASDAQ:SCPSScopus BioPharma Inc
03/04/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
02/18/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
01/20/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
01/20/20227:35AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:SCPSScopus BioPharma Inc
01/19/20225:07AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SCPSScopus BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:SCPS